Imran Eba

Imran is a partner at APVC in Cambridge, MA. He represents APVC on the Boards of Axon Therapies, Neuspera Medical and SetPoint Medical.

Before joining Action Potential, Imran was in the Worldwide Business Development group of GlaxoSmithKline working in a variety of business development and investing roles. Imran led the establishment of and headed up the Investment Management practice at GSK. The group was tasked with accessing technology and innovation external to GSK by making and managing investments in life science venture capital funds as limited partners and direct investments in biotechs made as part of GSK’s R&D collaborations.

Imran received his bachelor’s degree in finance from Concordia University in his native Canada and has trained as a Chartered Accountant. He serves on the Advisory Board of the Harvard HealthTech Fellowship, a 10-month fellowship that teaches the next generation of healthcare innovators how to harness technology, engineering, business, and cutting-edge science to define a new standard of medical care. Imran is a member of the Board of Trustees and the Investment Committee of the Hartford Seminary and is a member of the Board of Ambassadors of the Brooke Charter School a K-8 public charter school network in Boston dedicated to getting underserved students to and through college.